ICU SeaStar Medical Holding Corp.: ערך חשבונאי למניה

The book value per common share indicator reflects the asset dynamics of SeaStar Medical Holding (ICU), where the value 1.01 serves as the baseline metric. Growth is hindered by stringent FDA audits and integration into resuscitation protocols. Production relies on external contract manufacturers while the company maintains full patent ownership. The unique therapy architecture and regulatory humanitarian exemptions create an insurmountable barrier for new entrants in the kidney treatment niche.

SeaStar Medical Holding specializes in high-tech equipment for blood purification for patients with renal failure. By analyzing the net asset value per share, an investor can identify the residual capital value after all liabilities are settled, which allows them to filter out market volatility and assess the business's actual material base, determining its intrinsic stability and fundamental protection.